Objectives: Measurement of total hemoglobin, based on pulse co-oximetry, is a continuous and noninvasive method that has been principally evaluated in healthy volunteers subjected to hemodilution. We tested the hypothesis that its accuracy could adversely affect patients presenting with severe hemorrhage, which is traditionally associated with increased microvascular tone.
G astrointestinal bleeds are dramatic complications in digestive disorders and are associated with high rates of blood transfusion(s) and mortality (1) (2) (3) (4) . Because urgent diagnostic and therapeutic decisions are required, patients are often admitted to an intensive care unit (ICU), where hemoglobin (Hb) level is regularly determined to react promptly to a persistent or recurrent bleeding incident and to guide blood-transfusion decisions (4, 5) . Traditionally, accurate measurement of total Hb has required withdrawal of blood and determination using a spectrophotometric method. Although this technique is considered the reference method, it often requires a noncompressible delay before obtaining a result. Thus, it would be very useful to have a more rapid method to determine Hb concentration. Among the available devices, the capillary-based method, which allows total Hb determination at the bedside, is probably most used by physicians. However, its accuracy in clinical trials remains controversial (6) (7) (8) (9) (10) (11) (12) .
Recently, a continuous and noninvasive technology to measure Hb concentration, based on pulse co-oximetry (SpHb), has been developed. This method discerns the distinctive light-absorption characteristics of the different Hb species and applies proprietary algorithms to determine total Hb levels (13) (14) (15) (16) . A device that allows continuous monitoring of Hb concentration would reduce the time needed to obtain results and, by its continuous nature, alert healthcare providers to additional occult blood loss.
In healthy volunteers undergoing normovolemic hemodilution, Macknet et al (17) reported an average difference of 0.15 ± 0.92 g dL -1 in 335 paired simultaneously measured Hb levels determined by a laboratory co-oximeter vs. a SpHb-based method. Although this experimental condition allowed the authors to study a relatively large range of Hb levels (7.5-13.8) g dL -1 , the maintenance of normal-volume status undoubtedly induced less change in microvascular tone than ordinarily occurs during acute hemorrhage (18) . Furthermore, an intermediate dose of norepinephrine is often infused during the early phase of hemorrhagic shock to restore perfusion pressure and improve outcomes (19) . By accentuating physiopathological microvascular constriction, such an approach could impair the performance of the pulse sensor and worsen the accuracy of the SpHb-based method. In surgical patients with mild hemorrhage (mean perioperative blood loss of 600 mL), Lamhaut et al (20) reported discrepancies of >1 g dL -1 in 46% of cases that used SpHb compared with laboratory co-oximeterbased method.
Herein, this current observational study tested the hypothesis that determining Hb level using SpHb could be seriously flawed in patients admitted into an ICU for a severe gastrointestinal bleed, particularly those who suffer from physiologically associated and/or pharmacologically induced increased vasomotor tone.
MATERIALS AND METHODS
Approval was gained from our institutional review board (Comité de Protection des Personnes Sud-Ouest et Outre Mer III, agreement number DC2010/14) for this study. During the collection of data, the care of patients conformed to the standard procedures currently used in our institute, hence authorization was granted to waive informed consent for this study.
Experimental Protocol. Between March and July, 2010, all patients admitted to our ICU from the Haut-Lévêque Hospital, for management of a severe gastrointestinal bleed, were prospectively enrolled into this observational study. To preferentially include patients suffering from an acute hemorrhage, those in whom the last blood exteriorization occurred at >12 hrs previously were excluded. Patients with a skin or fingernail disease, patients with darkly pigmented skin, those in whom decreased accuracy of the pulse oximeter had been previously reported (21) , and moribund patients with a life expectancy of <24 hrs were also excluded.
Monitoring of patients included continuous electrocardiogram, intermittent noninvasive measurement of arterial blood pressure, pulse oximetry, and urinary output. Sedation, mechanical ventilation, and administration of catecholamine and antibiotics were left to the discretion of the attending physician. Similarly, more invasive techniques, such as central venous, and arterial or urinary catheters, were determined according to overall clinical management.
At admission, a spectrophotometric sensor (R1 25 and R2-25, Masimo, Irvine, CA) was positioned on the patient's second fingertip and connected to a self-calibrating pulse co-oximeter, Radical-7 running-board software version 7601 (Rainbow SET, Masimo). The sensor was maintained in total darkness using a specific small opaque bag. SpHb was started a few seconds after self-calibration. The pulse oximeter perfusion index (PI), shown on the device's screen, was systematically noted at each SpHb determination. The PI value was defined as the pulsatile signal indexed against the nonpulsatile signal, expressed as a percentage. From the pulse-oximetry data, the PI was calculated as the ratio of the variable amount of infrared light (940 nm) absorbed by the pulsating arterial inflow to the constant amount absorbed by the tissues and nonpulsatile blood (22) .
In patients admitted to our ICU for a gastrointestinal bleed, biological tests at admission systematically included a coagulation test and a venous blood-cell count using a venous-Hb (vHb) measurement made with a laboratory co-oximeter (LH 780-automate, Beckman Coulter, Brea, CA). The precision of this device, as reported by the manufacturer, is <0.8% (http://www.captodayonline.com/productguides/instruments/hematology-analyzers/ beckman-coulter-lh-780-hematology-2010. html). Hb level of capillary blood (cHb) was simultaneously determined at the bedside by taking a single drop of blood from a fingertip skin puncture and using a portable Hb meter HemoCue Hb 201 + (HemoCue, Meaux, France) to gain immediate assessment. The vHb was always taken from a new venipuncture site, and effort was made to take the vHb and cHb blood samples from an extremity that did not have intravenous fluids being actively infused. SpHb and PI were recorded while the blood samples were drawn, or were recorded within 1 min if SpHb and/or PI values were not immediately available on the screen. Conforming to the standard procedures for patients admitted to our ICU for a severe gastrointestinal bleed, measurement of Hb level was repeated every 8 hrs, and this included simultaneous determination of vHb, cHb, and SpHb level. We arbitrarily defined the first 24 hrs following admission to the ICU as the study period. Consequently, the length of the study period included the first four measurements of Hb. As mentioned earlier, this study conformed to the standard care given to patients in our ICU except for the use of the spectrophotometric sensor (R1 25 and R2-25, Masimo), which was positioned on the patient's finger.
End Point. The primary end point was the percentage of inaccurate absolute measurements, which were arbitrarily defined as a difference of >15% compared with the reference, or their unavailability for any technical reason. Inaccurate measurements were the proportion of measurements that we considered clinically unacceptable (23) . The secondary end points were bias, precision, and limit of agreement, for punctual measurement as well as percentage error. Because signal extraction technology uses multiwavelength spectrophotometry, which may be sensitive to the state of the microcirculation, the precision of SpHb was also compared between patients receiving or not receiving norepinephrine. We also determined the number of erroneous decisions made regarding number of transfusions (both too many and too few) that would have been made if a given threshold Hb concentration was used to prescribe a red-cell transfusion and data from the device. This analysis was also performed at different transfusion thresholds (6, 7, and 8 g dL -1 )
Calculation of Sample Size. The sample size was determined according to the number needed to demonstrate the accuracy of measurements. Our hypothesis was to determine whether the devices used in this study were able to produce at least 80% ± 10% accurate measurements. Assuming an α risk of 0.05, we estimated that 61 independent measurements were necessary. We planned to take four consecutive measurements per patient, and the number of patients required for the study was 33 (i.e., at least 132 measurements).
Statistical Analyses. Laboratory determination of Hb level was considered to be the reference method. Correlations between any two measurements were performed using the least-square method. Concordance between two measurements was evaluated using the Bland and Altman (24) method, with a correction for repeated measures. Bias was defined as the mean difference between the test and reference measurement, whereas precision was defined as the mean absolute value of this difference. The limits of agreement were calculated as the bias ± 1.96 sds. The percentage error was calculated as the ratio of the 1.96 sd of the bias to the mean and reference measurements. The impact of the pulse oximeter's PI on SpHb accuracy was also evaluated. Furthermore, as a post hoc analysis, we compared measurements performed between patients receiving and not receiving norepinephrine. Data are expressed as medians (extremes) or numbers (% of patients). Comparisons between means and proportions were performed using Student's t test and the chi-square test, respectively. All p values were two tailed, and a p value of < .05 was considered significant. Statistical analysis was performed with R (version 2.10) (http:// www.r-project.org).
RESULTS
During the 5-month study period, 75 consecutive patients were admitted to our ICU for a severe gastrointestinal bleed. Of these, 33 patients were included in our study (see flow chart in Fig. 1 ). The characteristics of the patients are summarized in Table 1 . The median length of each patient's study period was 24 (range: 22-30) hrs. Twenty-six patients (79%) received two or more red blood-cell-concentrate transfusions. The median number of transfused red bloodcell-concentrates during the study period was four units (range: 0-36). A total of 131 vHbs were performed. This means that one patient received three measurements of Hb level using the vHb reference method instead of the usual four measurements.
Of the 132 possible pulse co-oximetry Hb measurements, 25 (19%) were unavailable on the screen. These missing measurements were not related to technical error but to the inability of the spectrophotometric sensor to detect enough blood perfusion in the patient's fingertip, as attested by the absence of a PI value on the screen. Measurement of cHb was performed 105 times and provided appropriate data without any device malfunctions. In patients in whom vHb, cHb, and SpHb could be determined simultaneously (n = 93), the mean Hb concentrations were, respectively, 9.9 g dL -1 (6.8-16.2), 9.5 g dL -1 (5.3-15.4), and 8.9 g dL -l (3.6-14.0) (p < .01).
Accuracy of the Absolute Measurements of Hb Level Using SpHb and cHb. A significant correlation was found between SpHb and vHb (r 2 = 0.30; p < .001) ( Fig. 2A) . Similarly, cHb was significantly correlated with vHb (r 2 = 0.76; p < .001) ( Fig. 2B) . When vHb was compared with SpHb, the bias was 1.0 g dL -1 , and the limits of agreement were −2.7 g dL -1 to +4.7 g dL -1 (Fig. 3A) . vHb compared with cHb bias was 0.4 g dL -1 , and the limits of agreement were −1.6 g dL -1 to +2.4 g dL -1 (Fig. 3B) . The grey hatched areas in Figure 3 correspond to the accurate measurements (a difference of <15% compared to the reference). For SpHb and cHb, the proportions of accurate measurements were, respectively, 43% and 85% (p < .05). All variables related to the analysis of concordance are summarized in Table 2 .
Accuracy of Changes in Hb Level Using SpHb and cHb. As four measurements should have theoretically been performed in each patient, a total of 198 changes could be analyzed. For SpHb, 58 (29%) changes were unavailable due to technical reasons. In contrast, all measurements performed with cHb were available, enabling 144 changes to be analyzed. The relative changes in vHb were significantly correlated with the changes in SpHb (r 2 = 0.32; p < .001) and with cHb (r 2 =0.43; p < .001) ( Fig. 4A and B,  respectively) .
Factors Influencing the Accuracy of SpHb. There was no significant relationship between the relative difference, between SpHb and vHb, and the PIs (data not shown). Bias, precision, percentage error, and the proportion of inaccurate measurements were comparable between patients receiving and not receiving norepinephrine (Table 3) . However, the number of unavailable measurements related to inadequate PI was significantly higher in patients receiving norepinephrine (42% vs. 15%, p < .05). Table 4 . We found that erroneous decisions were more frequently observed when Hb level was determined by co-oximetry and that the requirement for transfusion was principally overestimated.
Erroneous Decisions About Transfusion. The range of erroneous decisions about transfusion that would have been made is summarized in

DISCUSSION
The main findings of this study on critically ill patients suffering from severe gastrointestinal bleeds are that: 1) in contrast to the capillary-blood method, the accuracy of pulse co-oximetry-based determination of Hb was not clinically acceptable; 2) there was a high proportion of unavailable measurements when pulse co-oximetry was used in this critically ill population (19%), particularly in patients receiving norepinephrine (42%); and 3) the lack of accuracy for pulse co-oximetry did not seem to be related to dysperfusion.
Although good data on Hb progression after an acute hemorrhage are lacking in the medical literature, many experts consider that the decision to prescribe redblood-cell transfusion should be based on physiological state or on the estimated amount of blood lost rather than on Hb concentration (25) . Indeed, acute bleeding immediately decreases intravascular volume, without altering Hb concentration, which only falls once fluids enter the blood to replace the volume lost. However, estimating blood loss can be complex, especially when rapid fluid resuscitation is given. In clinical practice, treating physicians do take the Hb level into account in making treatment and transfusion decisions.
The time taken to obtain results from laboratory co-oximeters can be lengthy. Such a delay can be prejudicial during the urgent management of patients suffering from severe hemorrhage. Although portable co-oximeters can provide rapid measurement of Hb from a single drop of blood, obtained from a fingertip skin puncture (capillary blood), the process cannot be considered noninvasive and remains a discontinuous process. Furthermore, the accuracy of such a device remains controversial (6) (7) (8) (9) (10) (11) (12) .
The availability of point-of-care testing, which includes total Hb assessment in a noninvasive and continuous manner, offers a valuable advantage. A new technology for measuring SpO 2 , called signal extraction technology (Masimo), using multiple wavelengths of light, has been developed to improve the accuracy of SpO 2 values, and was designed to continuously and noninvasively measure Hb concentration (26, 27) . Its distinctive light-absorption characteristics for different Hb species allows detection of oxyhemoglobin, carboxyhemoglobin, methemoglobin, and total Hb (13) (14) (15) (16) .
To date, only a few studies have evaluated the accuracy of pulse co-oximetry in determining Hb concentration (17) . Acceptable accuracy of this method in healthy volunteers, undergoing normovolemic hemodilution, has been reported (17) . However, determination of Hb using pulse co-oximetry has not been performed under clinical conditions. Indeed, the patients studied have not had acute hemorrhage or major comorbidity, organ dysfunction, or hemodynamic instability. Thus, this means that this methodology may not be suitable for patients with an acute gastrointestinal bleed.
Our patients were critically ill, and were suffering from severe hemorrhage that required fluid loading and blood transfusion(s). The strength of our present study was to evaluate a relatively large number of patients who had a large range of Hb levels. Furthermore, some patients in our study required vasopressors. In these conditions, we observed that the performance of the pulse co-oximeter to measure Hb level was relatively poor, and a large proportion of measurements were unavailable using this method.
This study was carried out in a specialized ICU that is a referent clinical center for gastrointestinal-bleed assessment. Numerous patients are treated every year, which is why rapid Hb-measurement techniques that can be carried out at the bedside are needed. We chose to enroll patients with an acute gastrointestinal bleed, whatever their hemodynamic status or severity of hemorrhage. The length of the study period per patient was arbitrarily limited to the first four measurements of Hb level to minimize bias, and to limit the study time to the acutemanagement period. We observed patients suffering from the severest hemorrhages, with the most precarious hemodynamic statuses (including norepinephrine infusion), and who needed a large number of blood transfusions, which frequently gave a poor signal index, a poor PI, and could lead to numerous noninterpretative SpHb values. The patients' results showed serious limitations when SpHb was used. When a major bleed occurs, major blood loss can cause vasoconstriction and major-organ dysfunction. Under these circumstances, SpHb is no longer measurable. An inability to detect perfusion with a signal extraction technology sensor on the fingertip was caused by major peripheral vasoconstriction and reduced blood volume. Although a lack of SpHb response was frequently observed in severe hemorrhage cases within our study, this occurred not only when the hemodynamics were precarious but also after hemodynamic restoration using volume expansion, blood transfusion, or a low-dose norepinephrine perfusion.
Despite significant correlations with the reference method for both SpHb and cHb, the Bland and Altman method suggested that the bias, precision, and limits of agreement for SpHb were not sufficient to substitute for the reference method. In contrast, cHb appeared to predict vHb more reliably in this study.
Previous studies have evaluated the accuracy of portable Hb meters to determine total Hb in capillary blood. Although some authors recommend the usage of Hb meters to guide transfusion in clinical practice (7, 9, 10) , the accuracy of these meters remains controversial. In patients admitted to ICUs for a gastrointestinal bleed, although a low mean difference (bias) of 0.06 g dL -1 ± 0.87 g dL -1 between Hb level determined by a laboratory and that from capillary-blood samples was reported by Van de Louw et al (8) , the authors found that 21% of the differences were >1 g dL -1 .
In a study of 140 surgical blood samples, Rippmann et al (7) reported a bias of 0.6 g dL -1 ± 0.6 g dL -1 between Hb levels determined by a central laboratory and those from a HemoCue system for capillary blood. A similar result was recently reported in patients admitted to a surgical ICU (6) . These latter findings are consistent with our present study. We found a mean bias of 0.4 g dL -1 ± 1.0 g dL -1 , and the proportion of accurate measurements exceeded 80% (i.e., 85%).
Conversely, in terms of the accuracy of SpHb, we could not confirm the accuracy of pulse co-oximetry-based determination of Hb, as has been previously reported by authors (17, 28) . In a study of healthy volunteers subjected to normovolemic hemodilution, Macknet et al (17) reported a low mean difference between 335 paired measurements. In another study, which principally included healthy volunteers, but also surgical patients (28), a similar performance was reported (bias = −0.16 g dL -1 ± 1.30 g dL -1 ). Because measurement of SpHb is dependent on perfusion quality, we hypothesize that the accuracy of SpHb could be affected during severe hemorrhage, which is characterized by increased microvascular tone. Our findings suggest that the accuracy of SpHb is clinically unacceptable in patients presenting with a severe gastrointestinal bleed. A large proportion of the measurements made by SpHb were unavailable. Globally, more than half the measurements were considered inaccurate in critically ill patients. However, we could not observe any significant relationship between SpHb-vHb and PI values, and we could not find any difference in concordance variables between the accuracy of SpHb in patients who received or did not receive norepinephrine. However, the unavailability of measurements was significantly increased when norepinephrine was infused (42% vs. 15%, p < .01).
To give clinicians a greater sense of our findings and of their impact on patient management, we determined the range of erroneous decisions regarding transfusion procedures that would have been made if the data from the device had been taken into account. Whatever the threshold, the erroneous decisions varied between 50% and 100%. Overestimation of the requirement for a transfusion was frequently observed.
The following points should be considered when assessing the clinical relevance of our results. First, the determination of Hb level from capillary blood was performed on only one blood sample from each patient. Consequently, the variability of determining Hb level using this technique, although clearly reported in the literature, was not assessed (29) . Second, although hypothermia could have induced vascular changes in the PI and/or Hb readings, neither core nor distal hand temperatures were recorded in our study. Third, although the manufacturer does not exclude co-oximeter use depending on skin pigment, we preferred to exclude patients with darkly pigmented skin to optimize the device's performance. Consequently, the performance of the SpHb technique could be worse, and certainly no better, if individuals with dark pigmented skin had been included in the study.
CONCLUSION
This study shows that the use of pulse co-oximetry to determine Hb level lacks accuracy in critically ill patients presenting with severe gastrointestinal bleed. According to these results, the use of this technique to guide transfusion decisions may be hazardous. In contrast, measurement of Hb level in capillary blood remains clinically acceptable, is more accurate, and should be the preferential test to rapidly determine Hb level in the context of a severe hemorrhage. 
